Association between changes in bodyweight and cardiovascular disease risk factors among obese Japanese patients with type 2 diabetes

• Published in: Journal of diabetes investigation Vol. 13; no. 9; pp. 1560 - 1566
• Main Authors: Yoshimura, Ran, Nakagami, Tomoko, Hasegawa, Yukiko, Oya, Junko, Babazono, Tetsuya
• Format: Journal Article
• Language: English
• Published: Japan John Wiley & Sons, Inc 01-09-2022; John Wiley and Sons Inc; Wiley
• Subjects: Antihypertensives; Blood pressure; Body mass index; Bodyweight reduction; Cardiovascular disease risk factors; Cardiovascular diseases; Cholesterol; Diabetes mellitus (non-insulin dependent); Hemoglobin; High density lipoprotein; Insulin resistance; Lipids; Obesity; Original; Risk factors; Serum lipids; Triglycerides; Type 2 diabetes; Womens health; Japan; Bodyweight reduction; Type 2 diabetes; Cardiovascular disease risk factors
• ISSN: 2040-1116; 2040-1124
• DOI: 10.1111/jdi.13809

Aims/Introduction
We aimed to assess the association between bodyweight reduction and cardiovascular disease risk factors, and to identify the minimum bodyweight reduction associated with significant improvement in cardiovascular disease risk factors among obese Japanese patients with type 2 diabetes.
Materials and Methods
The cohort comprised 1,753 patients with type 2 diabetes and body mass index ≥25 kg/m2, who visited our clinic between 2013 and 2016. Multivariable linear regression analysis was carried out to assess the relationship between bodyweight changes and glycated hemoglobin A1c, serum lipids and blood pressure. Analyses of covariance were carried out to compare mean changes in cardiovascular disease risk factors across six groups of bodyweight change, <−5%, −5% to <−3%, −3% to <−1%, −1% to <1% (reference), 1% to <3% and ≥3%.
Results
Log‐transformed bodyweight change had a significantly positive relationship with log‐transformed glycated hemoglobin A1c, triglycerides, low‐density lipoprotein cholesterol and systolic blood pressure changes, and a negative relationship with high‐density lipoprotein cholesterol, after adjusting for sex, age, duration of diabetes, body mass index, use of glucose‐lowering, lipid‐lowering and antihypertensive agents, and changes in the use of these medications. A mean change in glycated hemoglobin A1c was significantly improved only in the <−5% group compared with the reference. Mean changes in triglycerides were improved in all groups, and significantly in the <−5% group.
Conclusions
Bodyweight change was significantly associated with cardiovascular disease risk factor changes, and >5% bodyweight reduction was associated with improved glycated hemoglobin A1c.
Body weight change was significantly associated with cardiovascular disease risk factor changes, and more than 5% body weight reduction was associated with improved glycated hemoglobin A1c.